🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMetabolic Health & DiabetesGLP-1 and beta-cell preservation — looking for input Page 5

GLP-1 and beta-cell preservation — looking for input

steph_laguna Thu, Oct 31, 2024 at 6:17 AM 52 replies 2,916 viewsPage 5 of 11
AmyNC_wife
Member
634
2,890
Jun 2024
North Carolina
Oct 31, 2024 at 1:22 PM#21

Congrats steph_laguna!! You should be so proud of yourself. 🎉

Last edited: Oct 31, 2024 at 2:22 PM
20 4JessicaM_2024, TomFromTexas, mike.trainer_LA and 17 others
Reply Quote Save Share Report
pete_manc_UK
Senior Member
1,234
5,678
Mar 2024
Manchester, UK
Oct 31, 2024 at 1:39 PM#22

Reading this thread on GLP-1 and beta-cell hits close to home. Dad of 2 checking in — I started at 265 lbs and felt like I would tried everything.

11 months on tirz and I am a different person. Not just the 40 lbs lost — my energy, my mood, my relationship with food. All transformed.

If you are on the fence about GLP-1 and beta-cell — take the leap. It was the best health decision I have ever made. ❤️

33 2RunnerRach, TrialNerd_Beth, HPLC_Greg and 30 others
Reply Quote Save Share Report
Dr.Martinez
Medical Advisor
3,891
28,456
Nov 2023
Boston, MA
Online
Oct 31, 2024 at 1:56 PM#23

As a healthcare provider, I want to add some clinical context to this discussion on GLP-1 and beta-cell preservation .

Building on what AmyNC_wife said — the evidence base here is well-established. The key publications to reference are from the SURMOUNT program[1].

Key clinical points:

  1. Efficacy is dose-dependent and typically requires 4-5 weeks to reach steady state
  2. Side effect profile is predictable and usually manageable with standard protocols
  3. Monitoring should include baseline labs and follow-up at 3-month intervals
  4. Patient education significantly improves outcomes and adherence

Standard disclaimer: this is educational, not individualized medical advice.

References:
[1] See thread title for relevant study identification.
9 24rachel_ABQ, traveltech_sara, AttorneyGrant and 6 others
Reply Quote Save Share Report
CanadaChris
Member
234
890
Nov 2024
Toronto, CA
Oct 31, 2024 at 2:13 PM#24

pete_manc_UK — wow. This community is amazing.

Last edited: Oct 31, 2024 at 8:13 PM
49 5Dr.PulmRoch, maya_sedona, stefan_berlin and 46 others
Reply Quote Save Share Report
lucas_SP_BR
Member
456
1,890
Jun 2024
São Paulo, BR
Oct 31, 2024 at 2:30 PM#25

Adding my data to this GLP-1 and beta-cell discussion:

MetricBaselineMonth 5Month 8
Weight258 lbs233 lbs203 lbs
A1C7.2%6.0%5.4%
hsCRP7.04.00.8

Protocol: Semaglutide 1.7mg/wk, resistance training 3x/wk, protein 1.5g/kg/day.

3 4tampaLisa73, KarenAZ_mom, zoe_NC
Reply Quote Save Share Report
13456711

Similar Threads

SUSTAIN-6 to SELECT — the cardiovascular evidence timeline14 replies
GLP-1 and insulin resistance — HOMA-IR improvement data17 replies
Metabolic syndrome reversal criteria — how GLP-1 addresses all 55 replies
A1C target achievement rates — sema vs tirz comparison8 replies
SURPASS-CVOT: tirzepatide cardiovascular outcomes trial design3 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register